{"id":30331,"date":"2026-03-12T02:05:07","date_gmt":"2026-03-12T02:05:07","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/30331\/"},"modified":"2026-03-12T02:05:07","modified_gmt":"2026-03-12T02:05:07","slug":"stocks-to-buy-abb-india-venus-remedies-karnataka-bk-are-on-analyst-radar-markets-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/30331\/","title":{"rendered":"Stocks to buy: ABB India, Venus Remedies, Karnataka Bk are on analyst radar | Markets News"},"content":{"rendered":"<p><img class=\"img-fluid w-100 lazy-img\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/03\/1743184442-9026.jpg\" title=\"share market, trading\" alt=\"share market, trading\" width=\"826\" height=\"465\" loading=\"eager\" fetchpriority=\"high\" decoding=\"async\" style=\"width:100%;height:auto;max-width:100%;display:block;object-fit:cover\"\/><\/p>\n<p class=\"MainStory_captiontext__pELgL captiontext\">Stock Recommendations by Kunal Kamble<\/p>\n<p>2 min read  Last Updated : Mar 12 2026 | 6:52 AM IST<\/p>\n<p>&#13;<br \/>\n\tStock recommendations by Kunal Kamble, Bonanza<br \/>\n&#13;<br \/>\n\tABB India<\/p>\n<p>\t<a href=\"https:\/\/www.business-standard.com\/markets\/abb-india-ltd-share-price-242.html\" target=\"_blank\" rel=\"nofollow noopener\">ABB India<\/a> Limited has shown a strong recovery from the major demand zone near 4,800\u20135,000, where the stock formed a solid base supported by increased volumes. The price has now moved above key short- and medium-term moving averages, indicating improving momentum and a potential trend reversal. The recent breakout above the 6,200 resistance zone signals renewed buying interest and strengthening bullish sentiment. Additionally, the formation of higher highs and higher lows suggests continuation of the upward trend.\u00a0<br \/>\n\u00a0<\/p>\n<p>&#13;<br \/>\n\tBuy range: \u20b96,280\u00a0<\/p>\n<p>&#13;<br \/>\n\tStop-loss: \u20b95,800\u00a0<\/p>\n<p>&#13;<br \/>\n\tTarget: \u20b97,150\u00a0<\/p>\n<p>&#13;<br \/>\n\tVenus Remedies<\/p>\n<p>\t<a href=\"https:\/\/www.business-standard.com\/markets\/venus-remedies-ltd-share-price-4791.html\" target=\"_blank\" rel=\"nofollow noopener\">Venus Remedies<\/a> Limited has given a strong breakout above the key resistance zone near 830 on the daily chart, supported by a sharp bullish candle and noticeable rise in volumes, indicating strong buying interest. The stock is trading above its short- and medium-term moving averages, reflecting positive momentum and strengthening trend structure. Additionally, RSI has moved towards 69, suggesting improving bullish momentum without being extremely overbought.\u00a0\u00a0<br \/>\n\u00a0<\/p>\n<p>&#13;<br \/>\n\tBuy range: \u20b9862\u00a0<\/p>\n<p>&#13;<br \/>\n\tStop-loss: \u20b9786\u00a0<\/p>\n<p>&#13;<br \/>\n\tTarget: 1,050<\/p>\n<p>&#13;<br \/>\n\tKarnataka Bank<\/p>\n<p>\t<a href=\"https:\/\/www.business-standard.com\/markets\/karnataka-bank-ltd-share-price-5860.html\" target=\"_blank\" rel=\"nofollow noopener\">Karnataka Bank<\/a> Limited has recently shown a strong breakout from a long-term descending trendline on the daily chart, indicating a potential trend reversal. The stock witnessed increased buying interest supported by a surge in volumes, suggesting accumulation at lower levels. Prices have moved above the short- and medium-term moving averages, reflecting improving momentum. Additionally, the RSI is trending near 68, indicating strengthening bullish momentum.\u00a0<br \/>\n\u00a0<\/p>\n<p>&#13;<br \/>\n\tBuy range: \u20b9229\u00a0<\/p>\n<p>&#13;<br \/>\n\tStop-loss: \u20b9206\u00a0<\/p>\n<p>&#13;<br \/>\n\tTarget: \u20b9275\u00a0 (Disclaimer: This article is by Kunal Kamble, senior technical research analyst, Bonanza Portfolio. Views expressed are his own.)<\/p>\n<p>First Published: Mar 12 2026 | 6:45 AM IST<\/p>\n","protected":false},"excerpt":{"rendered":"Stock Recommendations by Kunal Kamble 2 min read Last Updated : Mar 12 2026 | 6:52 AM IST&hellip;\n","protected":false},"author":2,"featured_media":30332,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[130],"tags":[232,9952,18344,18339,18341,18342,9918,9920,18338,18345,18340,18343],"class_list":["post-30331","post","type-post","status-publish","format-standard","has-post-thumbnail","category-abb","tag-abb","tag-abb-india-share-price","tag-karnataka-bank-share-price","tag-stock-market-news","tag-stock-pics-today","tag-stock-recommendations","tag-stocks-in-news","tag-stocks-to-buy","tag-stocks-to-buy-today","tag-technical-calls-today","tag-technical-picks","tag-venus-remedies-share-price"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116213758264978536","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/30331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=30331"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/30331\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/30332"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=30331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=30331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=30331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}